Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.MedLink signs distribution agreement with Medicalis
MedLink will now offer the complete range of Medicalis solutions to provide its radiology customers with clinical decision support for diagnostic imaging, as well as facilitated management of
MedLink will now offer the complete range of Medicalis solutions to provide its radiology customers with clinical decision support for diagnostic imaging, as well as facilitated management of
Mr Paul has held CFO and vice president of finance positions with several manufacturers in agricultural machinery, hearing aids, and classic English knitwear. Horst Zerbe, president and CEO
Under the proposed terms of this arrangement, Huifeng will take over operational control of Qinba and will receive a management fee equal to all of Qinba’s profit. Jing’An
The company has also announced that Nawzer Mehta, vice president of clinical affairs, has tendered his resignation effective September 30, 2008 to pursue another opportunity. Ms Sheffield has
The Phase I trial will evaluate the safety and pharmacokinetics of a single intravenous dose of GMI-1070 at a range of dose levels. The initial Phase I trial
The clinical study will include patients with progressive, metastatic, hormone-refractory disease following prior taxane chemotherapy, and will assess the safety, tolerability and initial clinical activity of prostate-specific membrane
In April 2008, ESBATech initiated the Phase I study designed to evaluate the safety, tolerability and pharmacokinetic profile of ESBA105, when delivered topically via eye drops in healthy
The assay, FXG: RESP (Asp +), uses real-time PCR technology to accurately and rapidly identify infections caused by both Aspergillus and Pneumocystis, the company said. According to the
Under the terms of the agreement, Boehringer Ingelheim will continue research funding to Orexo in the OX-MPI project. Boehringer Ingelheim holds exclusive rights to all further compound development
Following the recommendation for regulatory approval under the European decentralized procedure, Toctino received its first national regulatory approval in the UK. Marketing applications for the use of alitretinoin